Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trial.

  • Authors : Koshino A; Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, the Netherlands.; Department of Nephrology and Laboratory Medicine, Kanazawa University, Ishikawa, Japan.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/diagnosis

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2023 Nov 28; Vol. 22 (1), pp. 330. Date of Electronic Publication: 2023 Nov 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

Record details

×
Academic Journal

Dapagliflozin and Anemia in Patients with Chronic Kidney Disease.

  • Authors : Koshino A; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Department of Nephrology and Laboratory Medicine, Kanazawa University, Ishikawa, Japan.

Subjects: Anemia* ; Diabetes Mellitus, Type 2* ; Glucosides*

  • Source: NEJM evidence [NEJM Evid] 2023 Jun; Vol. 2 (6), pp. EVIDoa2300049. Date of Electronic Publication: 2023 May 19.Publisher: NEJM Group, a division of the Massachusetts Medical Society Country of Publication: United States NLM ID: 9918317485806676

Record details

×
Report

Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial.

  • Authors : Koshino A; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Department of Nephrology and Laboratory Medicine, Kanazawa University, Ishikawa, Japan.

Subjects: Cardiovascular Diseases* ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2023 May; Vol. 25 (5), pp. 1413-1418. Date of Electronic Publication: 2023 Feb 06.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS.

  • Authors : Koshino A; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Department of Nephrology and Laboratory Medicine, Kanazawa University, Ishikawa, Japan.

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use

  • Source: Diabetes care [Diabetes Care] 2022 Nov 01; Vol. 45 (11), pp. 2644-2652.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  15 results for ""Koshino A""